SearchDictionaryMobileLogin

Jean-Louis Chiasson Selected Research

Type 2 Diabetes Mellitus (MODY)

05/2007Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
04/2007Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
07/2006Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
01/2006Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial.
04/2005Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.
03/2005The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
10/2004Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy.
07/2003Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
06/2002Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Articles by Research Topic

Disease

9Type 2 Diabetes Mellitus (MODY)
05/2007 - 06/2002
3Cardiovascular Diseases (Cardiovascular Disease)
01/2006 - 07/2003
2Hypertension (High Blood Pressure)
01/2006 - 07/2003
1Cystic Fibrosis (Mucoviscidosis)
11/2007
1Myocardial Infarction
10/2004

Drug/Important Bio-Agent (IBA)

8Glucose (Dextrose)FDA LinkGeneric
11/2007 - 07/2003
5AcarboseFDA LinkGeneric
01/2006 - 06/2002
1Nonesterified Fatty Acids (NEFA)IBA
05/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2007
1PPAR alphaIBA
04/2007
1AdiponectinIBA
03/2005